Praxbind Now Approved Nov 5, 2015 Brand: Praxbind Now Approved (idarucizumab), Injection Parent Company: Boehringer Ingelheim Drug Type: Prescription Drug Category: Campaign: now-approved Targeting: HCPs Patient Website: HCP Website: http://www.praxbind.com/